JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
Other Equity
JCR Pharmaceuticals Co Ltd
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Other Equity
¥865m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
31%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Equity
¥2.5T
|
CAGR 3-Years
98%
|
CAGR 5-Years
48%
|
CAGR 10-Years
20%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Equity
¥284B
|
CAGR 3-Years
37%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Equity
¥249.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Equity
¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
Astellas Pharma Inc
TSE:4503
|
Other Equity
¥533.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
29%
|
CAGR 10-Years
14%
|
See Also
What is JCR Pharmaceuticals Co Ltd's Other Equity?
Other Equity
865m
JPY
Based on the financial report for Mar 31, 2024, JCR Pharmaceuticals Co Ltd's Other Equity amounts to 865m JPY.
What is JCR Pharmaceuticals Co Ltd's Other Equity growth rate?
Other Equity CAGR 10Y
31%
Over the last year, the Other Equity growth was 581%.